Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors.

Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H.

Hum Pathol. 1997 Jun;28(6):734-9.

PMID:
9191009
2.

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.

Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J.

Hum Pathol. 2006 Aug;37(8):1042-9. Epub 2006 Jun 2.

PMID:
16867867
3.

E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.

Holcomb K, Delatorre R, Pedemonte B, McLeod C, Anderson L, Chambers J.

Obstet Gynecol. 2002 Dec;100(6):1290-5.

PMID:
12468176
4.

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH.

Clin Cancer Res. 2005 Sep 1;11(17):6116-26.

5.
6.

Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma.

Khin EE, Kikkawa F, Ino K, Suzuki T, Shibata K, Kajiyama H, Tamakoshi K, Mizutani S.

Int J Gynecol Pathol. 2003 Apr;22(2):175-80.

PMID:
12649673
7.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
8.

Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.

Marques FR, Fonsechi-Carvasan GA, De Angelo Andrade LA, Böttcher-Luiz F.

Gynecol Oncol. 2004 Jul;94(1):16-24.

PMID:
15262114
9.
10.

B7-H4 overexpression in ovarian tumors.

Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.

Gynecol Oncol. 2006 Jan;100(1):44-52. Epub 2005 Oct 26.

PMID:
16256178
11.

u-PA expression in benign, borderline and malignant ovarian tumors.

Kiziridou AD, Toliou T, Stefanou D, Agnantis N.

Anticancer Res. 2002 Mar-Apr;22(2A):985-90.

PMID:
12014682
12.

p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.

Am J Surg Pathol. 2007 May;31(5):653-63.

PMID:
17460447
14.

Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.

Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):226-32. doi: 10.1016/j.ejogrb.2008.01.004. Epub 2008 Mar 4.

PMID:
18295959
15.
17.

Inhibitory role of prohibitin in human ovarian epithelial cancer.

Jia L, Ren JM, Wang YY, Zheng Y, Zhang H, Zhang Q, Kong BH, Zheng WX.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2247-55. eCollection 2014.

18.

CD44 expression indicates favorable prognosis in epithelial ovarian cancer.

Sillanpää S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM.

Clin Cancer Res. 2003 Nov 1;9(14):5318-24.

19.

Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis.

Määttä M, Bützow R, Luostarinen J, Petäjäniemi N, Pihlajaniemi T, Salo S, Miyazaki K, Autio-Harmainen H, Virtanen I.

J Histochem Cytochem. 2005 Oct;53(10):1293-300. Epub 2005 May 27.

PMID:
15923364
20.

Supplemental Content

Support Center